Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Boston Medical Group vs Luma Meds

Boston Medical Group
Graded #113

Higher grade

vs+12.100000000000009
Luma Meds
Graded #391

Lower grade

The verdict

Boston Medical Group takes it — 69.9/100 to 57.8/100.

Boston Medical Group grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established medical group offering a 3-month semaglutide weight loss program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBoston Medical Group +54
86
32
Dose & formulationLuma Meds +12
52
64
Clinical oversightLuma Meds +1
89
90
Labs & monitoringLuma Meds +2
53
55
FulfillmentLuma Meds +11
65
76
Contract termsBoston Medical Group +35
55
20
Boston Medical Group · left barLuma Meds · right bar

The numbers

MetricBoston Medical GroupLuma Meds
WeighScore69.9/10057.8/100
GradeCC
Scorecard rank#113#391
Semaglutide$66/mo (starting dose, compounded)$249/mo (compounded)
TirzepatideNot disclosed$299/mo (compounded)
Coverage7 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Boston Medical Group

Graded #113 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Luma Meds

Graded #391 · C

Strengths

  • LegitScript certified — a credibility mark fewer compounded GLP-1 providers carry
  • Free discreet shipping and unlimited 24/7 support on every plan
  • Compounded semaglutide and tirzepatide from FDA-regulated 503A/503B pharmacies
  • '100,000+ members treated' claim with physician-supervised online care
  • 3-month bundle pricing brings semaglutide as low as $140/mo

Where it loses points

  • Compounding pharmacy partner not publicly named
  • States available not published
  • Monthly semaglutide ($249/mo) is above many lower-cost compounded competitors
  • No oral formulation options listed
  • Compounded medications are not FDA-approved

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard